Array BioPharma
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations (NCT02278133) | Array BioPharma | 2014-12-01 |
| LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma (NCT01820364) | Array BioPharma | 2013-11-01 |
| Safety and Efficacy of LEE011 and LGX818 in Patients With BRAF Mutant Melanoma. (NCT01777776) | Array BioPharma | 2013-07-01 |
| A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors (NCT01449058) | Array BioPharma | 2012-03-01 |
| A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer (NCT00862524) | Array BioPharma | 2009-03-01 |
| A Safety Study of ARRY-403 in Patients With Type 2 Diabetes (NCT00859755) | Array BioPharma | 2009-03-01 |
Track Array BioPharma automatically
Every clearance here is in the API, with alerts when new ones post.